Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Variable reliability of surrogate measures of insulin sensitivity after Roux-en-Y gastric bypass

Research output: Contribution to journalJournal articleResearchpeer-review

  1. In vivo and in vitro degradation of peptide YY3-36 to inactive peptide YY3-34 in humans

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mapping the calcitonin receptor in human brain stem

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Delayed growth, motor function and learning in preterm pigs during early postnatal life

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Body height and arterial pressure in seated and supine young males during +2 G centrifugation

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Influence of acute and chronic streptozotocin-induced diabetes on the rat tendon extracellular matrix and mechanical properties

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Adults with pathogenic MC4R mutations have increased final height and thereby increased bone mass

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Assessment of Islet Alpha- and Beta-Cell Function

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

View graph of relations

Roux-en-Y gastric bypass (RYGB) induces weight loss and improves insulin sensitivity when evaluated by the hyperinsulinemic-euglycemic clamp (HEC). Surrogate indices of insulin sensitivity calculated from insulin and glucose concentrations at fasting or after an oral glucose tolerance test (OGTT) are frequently used, but have not been validated after RYGB. Our aim was to evaluate whether surrogate indices reliably estimate changes in insulin sensitivity after RYGB. Four fasting (inverse-HOMA-IR, HOMA2-%S, QUICKI, revised-QUICKI) and three OGTT-derived surrogates (Matsuda, Gutt, OGIS) were compared with HEC-estimated peripheral insulin sensitivity (Rd or Rd/I, depending on how the index was originally validated) and the tracer-determined hepatic insulin sensitivity index (HISI) in patients with preoperative type 2 diabetes (n=10) and normal glucose tolerance (n=10) 1 week, 3 months and 1 year postoperatively. Post-RYGB changes in inverse-HOMA-IR and HOMA2-%S did not correlate with changes in Rd at any visit, but were comparable to changes in HISI at 1 week. Changes in QUICKI and revised-QUICKI correlated with Rd/I after surgery. Changes in Matsuda and Gutt did not correlate with changes in Rd/I and Rd, respectively, whereas OGIS-changes correlated with Rd-changes at 1 year post-RYGB. In conclusion, surrogate measures of insulin sensitivity may not reflect results obtained with gold standard methodology after RYGB, underscoring the importance of critical reflection when surrogate endpoints are used. Fasting surrogate indices may be particularly affected by post-RYGB changes in insulin clearance, whereas the validity of OGTT-derived surrogates may be compromised by the surgical rearrangements of the gut.

Original languageEnglish
JournalA J P: Regulatory, Integrative and Comparative Physiology (Online)
Volume312
Issue number5
Pages (from-to)797-805
ISSN1522-1490
DOIs
Publication statusPublished - 1 Jun 2017

    Research areas

  • Journal Article

ID: 49887810